Display options
Cite
Abazar E, Taghian F, Mardanian F, et al. Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome. Adv Biomed Res. 2015;4:68doi: 10.4103/2277-9175.153892.
Abazar, E., Taghian, F., Mardanian, F., & Forozandeh, D. (2015). Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome. Advanced biomedical research, 468. https://doi.org/10.4103/2277-9175.153892
Abazar, Elaheh, et al. "Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome." Advanced biomedical research vol. 4 (2015): 68. doi: https://doi.org/10.4103/2277-9175.153892
Abazar E, Taghian F, Mardanian F, Forozandeh D. Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome. Adv Biomed Res. 2015 Mar 25;4:68. doi: 10.4103/2277-9175.153892. eCollection 2015. PMID: 25878993; PMCID: PMC4386212.
Copy Download .nbib Format: NLM
Share it on

Adv Biomed Res. 2015 Mar 25;4:68. doi: 10.4103/2277-9175.153892. eCollection 2015.

Effects of aerobic exercise on plasma lipoproteins in overweight and obese women with polycystic ovary syndrome.

Advanced biomedical research

Elaheh Abazar, Farzaneh Taghian, Farahnaz Mardanian, Dashti Forozandeh

Affiliations

  1. Faculty of Physical Education and Sports Science, Islamic Azad University Khorasghan (Isfahan) Branch, Isfahan, Iran.
  2. Department of Obstetric and Gynecology, Isfahan University of Medical Sciences, Isfahan, Iran.
  3. Faculty of Nursing and Midwifery, Islamic Azad University Khorasghan (Isfahan) Branch, Isfahan, Iran.

PMID: 25878993 PMCID: PMC4386212 DOI: 10.4103/2277-9175.153892

Abstract

BACKGROUND: Polycystic ovary syndrome (PCOS) is one of the most frequent endocrine disorders. The PCOS manifest by hyperandrogenism, hypertension and cholesterol and lipoprotein improper profiles. Changing the life style, e.g. increasing physical activities is the first approach in controlling PCOS.

MATERIALS AND METHODS: Twenty-four women affected by polycystic ovary syndrome (PCOS) after medical screening were divided in to two groups: Experimental group (n = 12) and control group (n = 12), with the average age, weight, height, BMI and WHR of 26.87 ± 4.43 years, 75.71 ± 10.65 kg. 159.29 ± 6.44 cm, 29.86 ± 3.22 kg/m(2) and 91.75 ± 5.86 respectively. First the body composition such as BMI, WHR, percent body fat, weight and body fat mass were measured. In fasting blood samples the level of HDL, LDL, VLDL, triglyceride and cholesterol were measured. Then the experiment group underwent the effect of an aerobic exercise program. After 12 weeks, all the measured variables before intervention the test were re-measured. Correlated t-test was used for comparing the two groups before and after intervention the test and independent t-test was used for comparing the two groups (P < 0.05).

RESULTS: The results showed that after 12 weeks of exercise, BMI, WHR, fat rate, weight and fat mass and triglyceride had significant reduction and HDL had significant increase. But no significant changes happened in LDL, VLDL, and cholesterol levels.

CONCLUSION: Reducing the weight by aerobic exercise in obese women and affected by PCOS can correct lipoprotein profile and improving health.

Keywords: Aerobic sport; body compositions; plasma lipoproteins; polycystic ovary syndrome

References

  1. J Res Med Sci. 2011 Aug;16(8):999-1005 - PubMed
  2. Semin Reprod Med. 2008 Jan;26(1):93-100 - PubMed
  3. Am J Physiol Regul Integr Comp Physiol. 2009 Aug;297(2):R387-95 - PubMed
  4. J Clin Endocrinol Metab. 2011 Jan;96(1):E48-56 - PubMed
  5. Ann Med. 1992 Dec;24(6):465-8 - PubMed
  6. Obstet Gynecol Clin North Am. 2003 Jun;30(2):337-52 - PubMed
  7. Med Sci Sports Exerc. 2009 Mar;41(3):497-504 - PubMed
  8. J Clin Endocrinol Metab. 2002 Oct;87(10):4496-501 - PubMed
  9. Clin Obstet Gynecol. 2007 Mar;50(1):277-94 - PubMed
  10. Hum Reprod. 2008 Mar;23(3):642-50 - PubMed
  11. Curr Pharm Des. 2012;18(17):2482-91 - PubMed
  12. Nutr Cancer. 2000;38(2):158-62 - PubMed
  13. Clin Endocrinol (Oxf). 2008 Nov;69(5):792-8 - PubMed
  14. Hum Reprod. 1998 Jun;13(6):1502-5 - PubMed
  15. J Clin Endocrinol Metab. 2007 Apr;92(4):1379-84 - PubMed
  16. Appl Physiol Nutr Metab. 2006 Aug;31(4):384-91 - PubMed
  17. J Clin Endocrinol Metab. 2001 Apr;86(4):1626-32 - PubMed
  18. Horm Metab Res. 2011 Dec;43(13):977-9 - PubMed
  19. Hum Reprod Update. 2011 Mar-Apr;17(2):171-83 - PubMed
  20. Womens Health (Lond). 2009 Sep;5(5):529-40; quiz 541-2 - PubMed
  21. BMJ. 2003 Oct 25;327(7421):951-3 - PubMed
  22. J Clin Endocrinol Metab. 2005 Apr;90(4):1929-35 - PubMed
  23. J Endocrinol Invest. 1991 Nov;14(10):839-46 - PubMed
  24. J Clin Endocrinol Metab. 2008 Sep;93(9):3373-80 - PubMed
  25. Int J Fertil Womens Med. 1997 May-Jun;42(3):184-97 - PubMed

Publication Types